This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Pacira Pharmaceuticals, Inc.. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Mary DiGiorgi: Innovator in Pain Management
Introduction
Mary DiGiorgi is a prominent inventor based in Parsippany, NJ (US). She has made significant contributions to the field of pain management, particularly in the context of surgical procedures. With a total of 2 patents to her name, her work focuses on innovative methods for alleviating post-operative pain.
Latest Patents
Mary DiGiorgi's latest patents include groundbreaking methods for treating pain associated with total knee arthroplasty. One of her patents details a method of administering an adductor canal block in a patient using sustained-release liposomal anesthetic compositions. This method involves selecting an entry point for an injection needle, identifying key nerves in the leg, and administering a pharmaceutical composition that includes multivesicular liposomes.
Another significant patent addresses the treatment of post-operative pain via a sciatic nerve block. This method involves administering a pharmaceutical composition to the sciatic nerve, which includes bupivacaine phosphate encapsulated within multivesicular liposomes. These innovative approaches aim to enhance patient comfort and recovery following surgical interventions.
Career Highlights
Mary DiGiorgi is currently associated with Pacira Pharmaceuticals, Inc., where she continues to develop and refine her innovative techniques in pain management. Her work is instrumental in advancing the field and improving patient outcomes.
Collaborations
Mary collaborates with various professionals in her field, including her coworker Roy Winston. Their combined expertise contributes to the development of effective pain management solutions.
Conclusion
Mary DiGiorgi's contributions to pain management through her innovative patents reflect her dedication to improving patient care. Her work at Pacira Pharmaceuticals, Inc. continues to pave the way for advancements in surgical pain relief.
